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and T cells (>10days).
Conclusions: The amount of renal epithelial cells in the urine seems
to directly reﬂect tissue damage in AKI. Immune cells can be
monitored in the urine of patients with AKI and persisted longer
than the renal injury itself. This suggests that immune cells
participate in mediating damage and tissue repair in human AKI.
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Introduction: The mechanism of injury to podocytes in focal
segmental glomerulosclerosis (FSGS) remains unclear. Both B7.1
(CD80) and suPAR have been proposed to cause FSGS but these
ﬁndings have not been validated. To survey these markers as po-
tential mediators of podocyte injury and as an aid to histologic
diagnosis of FSGS we evaluated the immunohistochemical expres-
sion of (1) B7-1 and suPAR in native and transplant kidney bi-
opsies, and (2) suPAR in an experimental mouse model of FSGS.
Methods: Consecutive kidney biopsies from the surgical pathology
ﬁles were selected for study groups of FSGS (n¼10) and early post-
transplant recurrent FSGS (n¼10). Native kidney biopsies with
membranous nephropathy (MN) (n¼10) and minimal change dis-
ease (MCD (n¼5), and 6 month post-transplant protocol biopsies
with normal morphology [n¼10] served as controls. Immunostains
for B7.1 and suPAR were performed on formalin-ﬁxed parafﬁn-
embedded and frozen sections with immunoperoxidase (IHC) or
immunoﬂuorescent (IF) methodology and the localization of the
positive signal was determined via co-stain with podocyte marker
synaptopodin. Appropriate positive method controls were avail-
able. In addition, uPAR expression was assessed in the kidneys of
wild type and suPAR deﬁcient (suPAR -/-) mice infused with
suPAR. The mouse kidneys were also evaluated by electron mi-
croscopy in conjunction with renal functional studies.
Results: B7.1 was not expressed in native kidneys with FSGS or
MCD or in transplant kidneys with recurrent FSGS. In MN, B7.1
was localized only to the immune deposits. No apparent suPAR
immunoreactivity was present in native kidneys or recurrent FSGS.
suPAR infusion did not produce proteinuria or effacement of
podocytes in wild type or suPAR deﬁcient mice. uPAR was
detected by IHC along the glomerular endothelial cells but not in
podocytes in wild type mice while uPAR stains remained negative
in suPAR deﬁcient mice even after suPAR injection.
Conclusions: The data suggest that B7.1 and suPAR may not play a
signiﬁcant role in podocyte injury in native and transplant kidneys
with FSGS. B7.1 and suPAR immunostains have a limited value as
diagnostic immunophenotypical markers in routine kidney biopsies
with FSGS and recurrent FSGS post-transplant.
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Introduction: The relevance of oxidative stress in systemic lupus
erythematosus (SLE) in humans is not fully understood. Moreover,
none of the previous studies have speciﬁcally studied the impact of
oxidative stress in patients of lupus nephritis. We conducted this
study to evaluate the markers of oxidative stress in patients of SLE
with or without lupus nephritis and to correlate them with clinical
presentation, disease activity, and type & severity of renal
manifestations.
Methods: This was a prospective study including patients diag-
nosed to have SLE on the basis of ACR criteria. The study partic-
ipants were divided into two groups depending on presence or
absence of renal involvement, which was deﬁned as either abnor-
malities in renal function test (serum creatinine$1.2mg/dl) or urine
examination (urine protein excretion $500mg/day or presence of
RBCs in urine) along with renal biopsy evidence of lupus nephritis.
After inclusion, patient’s particulars were noted including clinical
manifestations, investigations, SLE Disease Activity Index (SLE-
DAI), details of renal involvement, renal biopsy, treatment received
and the outcome. In both the groups, an additional 5 ml of venous
blood sample was drawn after overnight (8-10 hours) fasting for
analyzing the markers of oxidative stress. We studied Malondial-
dehyde (MDA) and Isoprostane as markers of lipid peroxidation;
reactive nitrogen intermediates (RNI) as markers of oxidative pro-
tein damage; 8-hydroxy deoxy guanosine as marker of oxidative
DNA damage and Superoxide dismutase (SOD) as a marker of
antioxidant activity.
Results: During the study period a total of 120 cases were included
(60 without lupus nephritis, 60 with lupus nephritis). The mean age
of study population was 29  9 years and 115 were females.
SLEDAI was signiﬁcantly higher in patients with nephritis as
compared to non-nephritis group. The mean values of serum MDA,
8-Isoprostane, 8-Hydroxy 2-deoxyguanosine and RNI were signif-
icantly higher in nephritis group, while there was no difference in
the levels of SOD. Signiﬁcant positive correlations were observed
between RNI and SLEDAI score (r ¼ 0.333, p<0.01), and MDA and
SLEDAI score (r ¼ 0.269, p<0.01), while none of the markers
showed signiﬁcant correlation with serum creatinine. There was no
signiﬁcant correlation between these markers and severity of renal
dysfunction, while 8-Hydroxy 2-deoxy guanosine levels showed
signiﬁcant negative correlation with degree of proteinuria (r¼
-0.345; p value 0.007). MDA levels were signiﬁcantly higher in
patients with proliferative lupus nephritis as compared to non
proliferative nephritis. During six months follow-up, we noted 7
deaths in nephritis group as compared to none in non-nephritis
group. The mean value of 8-Hydroxy 2-deoxy guanosine was
signiﬁcantly higher in those who died; however there was no sig-
niﬁcant difference in other oxidative markers.
Conclusions: SLE patients with nephritis have higher levels of
oxidative stress. Increased oxidative stress in nephritis patients
correlates more with SLEDAI than with type or severity of renal
dysfunction.
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